Skip to main content
Clinical Trials/NCT06469606
NCT06469606
Not yet recruiting
Not Applicable

A Cohort Study on feMale Patients' mammogRaphic texturE featureS: the COMPRESS Trial

Tampere University Hospital0 sites200 target enrollmentJune 17, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Tampere University Hospital
Enrollment
200
Primary Endpoint
Mammographic texture features
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.

Registry
clinicaltrials.gov
Start Date
June 17, 2024
End Date
December 15, 2038
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Candidate is a biological female aged 18 years or above;
  • Candidate is willing and able to give informed consent and gives their written consent for the participation in the study;
  • There is a clinical indication for a uni- or bilateral mastectomy

Exclusion Criteria

  • Candidate lacks the capacity to provide informed consent;
  • Candidate has breast implants

Outcomes

Primary Outcomes

Mammographic texture features

Time Frame: Through study completion, an average of 5 year

Aim: to evaluate how imaging parameters affect the mammographic texture features

Secondary Outcomes

  • Biological features(through study completion, an average of 10 year)

Similar Trials